Stephen P McKenna
Overview
Explore the profile of Stephen P McKenna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhaenens B, van Dijk S, Taal W, Noordhoek D, Coffey A, McKenna S, et al.
J Patient Rep Outcomes
. 2024 Mar;
8(1):33.
PMID: 38499890
Background: Half of the patients with Neurofibromatosis type 1 (NF1) develop one or more tumours called plexiform neurofibromas, which can have a significant impact on Quality of Life (QoL). The...
2.
Pencheva D, Coffey A, McKenna S, Monov S
Clin Rheumatol
. 2023 Mar;
42(7):1811-1817.
PMID: 36913029
Objective: Systemic lupus erythematosus (SLE) is a heterogeneous disease with multiple clinical manifestations, which causes a significant deterioration in the quality of life (QoL). The Systemic Lupus Erythematosus Quality of...
3.
Heaney A, de Oliveira R, Bizzi M, Correa R, Pereira M, Simao Mol S, et al.
F1000Res
. 2021 Oct;
9:1399.
PMID: 34621522
The Nottingham Health Profile (NHP) is a generic measure of perceived distress that has been used widely as an outcome measure in clinical practice and trials. The availability of two...
4.
Heaney A, McKenna S, Hagell P
J Nurs Meas
. 2021 Sep;
PMID: 34518414
Background And Purpose: The Unidimensional Fatigue Impact Scale (U-FIS) was developed for use in a multiple sclerosis population. The aim was to determine whether the U-FIS is a valid tool...
5.
McKenna S, Heaney A, Langley P
Innov Pharm
. 2021 Aug;
12(2).
PMID: 34345514
Over the past 40 years literally thousands of generic and disease specific patient reported outcome (PRO) instruments have been developed. While most were developed for a specific study and were...
6.
Langley P, McKenna S
Innov Pharm
. 2021 Aug;
12(2).
PMID: 34345508
The quality adjusted life year (QALY) has serious problems related to its failure to adhere to measurement theory. If a QALY is to be meaningful, the utility score that translates...
7.
8.
9.
McKenna S, Heaney A
J Med Econ
. 2021 Mar;
24(1):502-511.
PMID: 33759686
As test-developers we have often been troubled by published reviews of patient-reported outcome measures (PROMs). Too often minor issues are judged important while other reviews exclude the best measures available....
10.